Company profile: Reverie Labs
1.1 - Company Overview
Company description
- Provider of machine learning-driven preclinical drug development solutions, applying supervised deep learning, virtual screening, computational chemistry, and algorithmic molecular generation for lead discovery and optimization. Offers molecular property prediction (on-target binding, toxicity, ADMET), rich representations for small molecules and proteins, and a pipeline of wholly-owned and partner-developed drug candidates.
Products and services
- Virtual Screening: Executes high-throughput virtual screening by enumerating and evaluating millions of compounds in virtual libraries, integrating medicinal chemistry expertise with machine-learning models for hit identification
- Supervised Machine Learning (ML): Engineers custom-engineered deep-learning architectures to predict molecular properties such as on-target binding, toxicity, and ADMET, driving lead discovery and optimization across preclinical programs
- Algorithmic Molecular Generation: Produces computationally-driven molecular generation using genetic algorithms and continuous latent models to generate selective, synthesizable, stable, tissue-penetrant molecules
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Reverie Labs
Kadrige
HQ: France
Website
- Description: Provider of Software-as-a-Service (SaaS) e-detailing and collaborative solutions, offering project management, IT solutions implementation, technical integration, customization, consulting, and support services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kadrige company profile →
Tx3
HQ: United States
Website
- Description: Provider of automated quality and compliance SaaS solutions for software testing within Life Science companies, enabling agile adoption and efficient adherence to regulatory requirements such as 21 CFR Part 11. Offerings include Tricentis Tosca, qTest, NeoLoad, LiveCompare, and Data Integrity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tx3 company profile →
Ampersand Biomedicines
HQ: United States
Website
- Description: Provider of programmable medicines and platforms that precisely target disease sites, including AND-Body Therapeutics for disease-specific precision and modification; the AND-Platform, a computational and experimental system enabled by a proprietary Address Map; the Opportunity Atlas for identifying localized targets; and enhanced biologic generation via AbCheck’s antibody discovery technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ampersand Biomedicines company profile →
Stacs DNA
HQ: United States
Website
- Description: Provider of sample tracking software for forensics and healthcare.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stacs DNA company profile →
Wisecube
HQ: United States
Website
- Description: Provider of a hybrid cloud graphical AI platform focused on life science research acceleration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wisecube company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Reverie Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Reverie Labs
2.2 - Growth funds investing in similar companies to Reverie Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Reverie Labs
4.2 - Public trading comparable groups for Reverie Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →